DOI: 10.1046/j.1464-410x.2002.02738.x Koeth RA, Wang Z, Levison BS, et al
Rennick JJ, Johnston APR, Parton RG
It is also good to hear about the safety profile of these new oral GLP-1RA drugs especially the liver results and it will be good to see the data in a full publication in due course, Professor Naveed Sattar, Professor of Cardiometabolic Medicine/Honorary Consultant, University of Glasgow shared
One daily dose working on plantar fasciitis, Achilles soreness, and peripheral neuropathy simultaneously
For patients with diabetes, dyslipidaemia or other relevant conditions, appropriate tests may include renal function, HbA1c, and lipid profiles as clinically indicated and per local protocols